CRIG
CELG

Charter Research & Investment Group’s Celgene Corp CELG Stock Holding History

Charter Research & Investment Group’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-12,757
Closed -$1.27M – 80
2019
Q3 		$1.27M Sell
12,757
-100
-0.8% -$9.5K 1.37% 25
2019
Q2 		$1.19M Sell
12,857
-605
-4% -$57.5K 1.32% 31
2019
Q1 		$1.27M Sell
13,462
-575
-4% -$50.3K 1.4% 30
2018
Q4 		$900K Sell
14,037
-1,827
-12% -$135K 1.14% 34
2018
Q3 		$1.42M Sell
15,864
-530
-3% -$46.8K 1.55% 25
2018
Q2 		$1.3M Hold
16,394
– – 1.49% 32
2018
Q1 		$1.46M Buy
16,394
+40
+0.2% +$3.84K 1.75% 24
2017
Q4 		$1.71M Buy
+16,354
New +$1.85M 1.92% 20
2016
Q3 		$2.08M Buy
19,934
+90
+0.5% +$9.74K 2.44% 14
2016
Q2 		$1.96M Buy
19,844
+205
+1% +$21.2K 2.24% 19
2016
Q1 		$1.97M Sell
19,639
-440
-2% -$45.3K 2.25% 18
2015
Q4 		$2.4M Buy
20,079
+4,140
+26% +$479K 2.79% 11
2015
Q3 		$1.72M Sell
15,939
-3,015
-16% -$374K 2.28% 17
2015
Q2 		$2.19M Buy
+18,954
New +$2.17M 2.44% 14

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $488M AUM 17.59% 1-Year Est. Return

Charter Research & Investment Group's CELG Position: Q4 2019 in Review

Charter Research & Investment Group sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 12,757 shares — an estimated $1.27M sold.

Charter Research & Investment Group first reported a position in CELG in Q2 2015 and held it in 14 quarters. The position peaked at $2.4M in Q4 2015. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Charter Research & Investment Group reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Charter Research & Investment Group sold 12,757 Celgene Corp shares in Q4 2019, an estimated $1.27M.
  • Charter Research & Investment Group first reported a position in Celgene Corp in Q2 2015 and held it in 14 quarters.
  • Charter Research & Investment Group's Celgene Corp position peaked at $2.4M in Q4 2015.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Charter Research & Investment Group's 13F filing for Q4 2019, filed 30 Jan 2020.